Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients
- PMID: 15861353
- DOI: 10.1053/j.ajkd.2005.01.006
Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients
Abstract
Background: It recently was suggested that sleep apnea syndrome (SAS) is associated with the cardiovascular complications and outcomes seen in patients with end-stage renal disease (ESRD). This study investigates the association of SAS with coronary artery disease and antioxidant status in patients with ESRD.
Methods: Twenty-six hemodialysis patients underwent overnight polysomnography to evaluate sleep parameters. We performed multirow spiral computed tomography to derive coronary artery calcification (CAC) scores as an indicator of the severity of coronary artery disease and measured predialysis serum total antioxidant status (TAS) as a marker of antioxidant defenses.
Results: Nine of 26 patients had normal to mild SAS with an apnea-hypopnea index (AHI) less than 15, 9 patients had moderate SAS with an AHI of 15 to 30, and the remaining 8 patients had severe SAS with an AHI greater than 30. AHI and oxygen desaturation index (ODI) were strongly interrelated (r = 0.754; P < 0.001). CAC severity was associated with SAS severity: median CAC scores increased (P = 0.009) with increasing AHI category. However, values for TAS were not significantly different among the 3 AHI categories. CAC score also correlated positively (r = 0.564; P = 0.003) with ODI, and TAS correlated negatively (r = -0.539; P = 0.005) with ODI.
Conclusion: These results suggest that frequent oxygen desaturation triggered by SAS is associated with severe coronary artery disease and decreased antioxidant status in patients with ESRD. However, conclusions from this study should be drawn with caution because of its methodological limitations (cross-sectional design, heterogeneity of study population, and small number of patients).
Similar articles
-
Serum malondialdehyde and coronary artery disease in hemodialysis patients.Am J Nephrol. 2004 Sep-Oct;24(5):537-42. doi: 10.1159/000081731. Epub 2004 Oct 26. Am J Nephrol. 2004. PMID: 15523169
-
Sleep apnea syndrome, inflammation and oxidative stress in hemodialysis patients.Hemodial Int. 2018 Apr;22(2):209-216. doi: 10.1111/hdi.12565. Epub 2017 Apr 20. Hemodial Int. 2018. PMID: 28425583
-
Effects of nocturnal oxygen therapy on sleep apnea syndrome in peritoneal dialysis patients.Clin Nephrol. 2008 Oct;70(4):332-9. doi: 10.5414/cnp70332. Clin Nephrol. 2008. PMID: 18826859
-
Association between apnea-hypopnea index and coronary artery calcification: a systematic review and meta-analysis.Ann Med. 2021 Dec;53(1):302-317. doi: 10.1080/07853890.2021.1875137. Ann Med. 2021. PMID: 33522282 Free PMC article.
-
Pulmonary hypertension in end-stage renal disease.Respir Med. 2020 Apr;164:105905. doi: 10.1016/j.rmed.2020.105905. Epub 2020 Feb 19. Respir Med. 2020. PMID: 32094103 Review.
Cited by
-
Nocturnal sleep related with metabolic markers in end-stage renal disease patients receiving hemodialysis.Psychiatry Investig. 2009 Mar;6(1):34-8. doi: 10.4306/pi.2009.6.1.34. Epub 2009 Mar 31. Psychiatry Investig. 2009. PMID: 20046371 Free PMC article.
-
Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis.Clin J Am Soc Nephrol. 2011 May;6(5):986-94. doi: 10.2215/CJN.05720710. Epub 2011 Mar 24. Clin J Am Soc Nephrol. 2011. PMID: 21441128 Free PMC article.
-
Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis.Clin Kidney J. 2023 Nov 14;17(1):sfad179. doi: 10.1093/ckj/sfad179. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186876 Free PMC article.
-
A systematic review of sleep disorders in patients with chronic kidney disease undergoing hemodialysis.J Phys Ther Sci. 2016 Jul;28(7):2164-70. doi: 10.1589/jpts.28.2164. Epub 2016 Jul 29. J Phys Ther Sci. 2016. PMID: 27512289 Free PMC article.
-
Mechanisms of endothelial dysfunction in obstructive sleep apnea.Vasc Health Risk Manag. 2008;4(6):1327-35. doi: 10.2147/vhrm.s4078. Vasc Health Risk Manag. 2008. PMID: 19337546 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical